固有淋巴细胞的发育、分化及多样性
Development, differentiation, and diversity of innate lymphoid cells.
作者信息
Diefenbach Andreas, Colonna Marco, Koyasu Shigeo
机构信息
Research Centre for Immunology and Immunotherapy, University of Mainz Medical Centre, Obere Zahlbacher Strasse 67, 55131 Mainz, Germany; Institute of Medical Microbiology and Hygiene, University of Mainz Medical Centre, Obere Zahlbacher Strasse 67, 55131 Mainz, Germany.
Department of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid, St. Louis, MO 63110, USA.
出版信息
Immunity. 2014 Sep 18;41(3):354-365. doi: 10.1016/j.immuni.2014.09.005.
Recent years have witnessed the discovery of an unprecedented complexity in innate lymphocyte lineages, now collectively referred to as innate lymphoid cells (ILCs). ILCs are preferentially located at barrier surfaces and are important for protection against pathogens and for the maintenance of organ homeostasis. Inappropriate activation of ILCs has been linked to the pathogenesis of inflammatory and autoimmune disorders. Recent evidence suggests that ILCs can be grouped into two separate lineages, cytotoxic ILCs represented by conventional natural killer (cNK) cells and cytokine-producing helper-like ILCs (i.e., ILC1s, ILC2s, ILC3s). We will focus here on current work in humans and mice that has identified core transcriptional circuitry required for the commitment of lymphoid progenitors to the ILC lineage. The striking similarities in transcriptional control of ILC and T cell lineages reveal important insights into the evolution of transcriptional programs required to protect multicellular organisms against infections and to fortify barrier surfaces.
近年来,人们发现固有淋巴细胞谱系中存在前所未有的复杂性,现在这些细胞统称为固有淋巴细胞(ILC)。ILC优先定位于屏障表面,对于抵御病原体和维持器官内稳态至关重要。ILC的不适当激活与炎症和自身免疫性疾病的发病机制有关。最近的证据表明,ILC可分为两个独立的谱系,以传统自然杀伤(cNK)细胞为代表的细胞毒性ILC和产生细胞因子的辅助样ILC(即ILC1、ILC2、ILC3)。我们将在此重点讨论人类和小鼠的当前研究工作,这些研究确定了淋巴祖细胞定向分化为ILC谱系所需的核心转录调控机制。ILC和T细胞谱系转录控制方面的显著相似性,为保护多细胞生物免受感染和强化屏障表面所需转录程序的进化提供了重要见解。
相似文献
Immunity. 2014-9-18
Cytokine Growth Factor Rev. 2018-8
Front Immunol. 2019-2-8
Immunity. 2014-9-18
Protein Cell. 2017-4
Curr Opin Immunol. 2016-2
Trends Immunol. 2020-5
引用本文的文献
Immunol Res. 2025-4-16
Front Immunol. 2025-2-28
Einstein (Sao Paulo). 2024-11-29
Exp Hematol Oncol. 2024-11-13
Proc Natl Acad Sci U S A. 2024-11-5
本文引用的文献
J Exp Med. 2014-8-25